Suppr超能文献

子宫内暴露于替诺福韦对乳牙的影响。

Influence of tenofovir exposure in utero on primary dentition.

机构信息

Department for Infectious Diseases, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Department of Pediatrics and Adolescent Medicine, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

出版信息

Eur J Pediatr. 2020 Nov;179(11):1761-1768. doi: 10.1007/s00431-020-03660-1. Epub 2020 May 19.

Abstract

Tenofovir disoxoproxil fumarate (TDF) is recommended for antiretroviral treatment for pregnant women living with HIV. As a comparative method to study bone density, we investigated the influence of in utero tenofovir exposure on the prevalence and distribution of developmental defects of enamel (DDE) in the primary dentition, as the mineralization process in teeth is higher and more complex and thus more vulnerable. HIV-exposed children with in utero exposition to tenofovir were included in this prospective observational single-center study. Dental status and enamel defects were assessed by an experienced dentist following a standardized protocol. Further information was collected using a standardized questionnaire, available in German and English. The prevalence of developmental defects in children with intrauterine tenofovir exposure was compared with literature data from a recent study of 377 healthy children in Germany and literature data from a study of 1221 healthy African children. Thirty-one children (mean age 2.1 ± 0.3 years; 41.9% female) were included. Median tenofovir exposure in utero was 28 weeks (mean ± 10.52 SD). Prevalence of developmental defects in the primary dentition in tenofovir-exposed children was similar compared to data of unexposed children (16.1% vs. 5.3%, p = 0.051 (compared to German cohort); 16.1% vs. 33.3%, p = 0.068 (compared to African cohort)).Conclusion: HIV-uninfected infants with in utero exposure to TDF showed no significant differences in the prevalence of DDE in comparison to cross-sectional data of HIV- and TDF-unexposed children; thus, the in utero exposure to TDF did not negatively influence the prevalence or distribution of DDE. What is Known: • There are no data available on the prevalence of developmental defects of enamel (DDE) in the primary dentition in intrauterine HIV- and tenofovir-exposed children. • Conclusions can be drawn from intrauterine milk tooth development to bone development and mineralization. What is New: • Prevalence of developmental defects in the primary dentition in tenofovir-exposed children was similar compared to data of unexposed children. • Preterm birth and hospitalization did not show a significant association on the prevalence of developmental defects in the primary dentition.

摘要

富马酸替诺福韦二吡呋酯(TDF)被推荐用于 HIV 感染孕妇的抗逆转录病毒治疗。我们通过研究子宫内替诺福韦暴露对乳牙釉质发育不全(DDE)的流行和分布的影响,作为研究骨密度的比较方法,因为牙齿的矿化过程更高、更复杂,因此更容易受到影响。这项前瞻性观察性单中心研究纳入了子宫内暴露于替诺福韦的 HIV 暴露儿童。经验丰富的牙医按照标准化方案评估牙齿状况和牙釉质缺陷。进一步的信息通过一份标准化问卷收集,该问卷有德语和英语两种版本。将子宫内暴露于替诺福韦的儿童的发育缺陷患病率与德国最近一项针对 377 名健康儿童的研究和一项针对 1221 名健康非洲儿童的研究的文献数据进行了比较。纳入了 31 名儿童(平均年龄 2.1±0.3 岁;41.9%为女性)。中位数子宫内替诺福韦暴露时间为 28 周(平均±10.52 SD)。与未暴露儿童相比,替诺福韦暴露儿童乳牙发育缺陷的患病率相似(16.1% vs. 5.3%,p=0.051(与德国队列相比);16.1% vs. 33.3%,p=0.068(与非洲队列相比))。结论:与 HIV 和 TDF 未暴露儿童的横断面数据相比,子宫内暴露于 TDF 的 HIV 未感染婴儿的 DDE 患病率无显著差异;因此,子宫内暴露于 TDF 并未对 DDE 的患病率或分布产生负面影响。已知:• 关于子宫内 HIV 和替诺福韦暴露儿童乳牙釉质发育不全(DDE)的患病率,尚无数据。• 可以从子宫内乳齿发育推断到骨骼发育和矿化。新发现:• 与未暴露儿童相比,替诺福韦暴露儿童乳牙发育缺陷的患病率相似。• 早产和住院治疗与乳牙发育缺陷的患病率无显著相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验